Photo of Marleen Kok from avl.nl
Jul 1, 2025, 02:44
Marleen Kok: Neoadjuvant Immunotherapy Landscape – New Insights with a Stellar Team
Marleen Kok, Group Leader (Associate professor) at The Netherlands Cancer Institute, sharef a post on LinkedIn:
“For an update on the rapidly evolving landscape of neoadjuvant immunotherapy in different cancer types, read our review. It was such a pleasure to write it with a stellar team: ESMO fellow Gil Awada and my amazing colleagues Michiel van der Heijden, Prof Dr Christian Blank, Myriam Chalabi, Tina Cascone.”
Title: The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types
Authors: Gil Awada, Tina Cascone, Michiel S. van der Heijden, Christian U. Blank, Marleen Kok, Myriam Chalabi
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:55
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04